Welcome to South West Healthcare
Leaders in healthcare, partners in wellbeing.
Please use this identifier to cite or link to this item:
https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3698| Journal Title: | The effect of 12 months' treatment with eicosapentaenoic acid in five children with Cystic Fibrosis |
| Authors: | Thies, Nick H. |
| SWH Author: | Thies, Nick H. |
| Keywords: | Adolescent Child Clinical Article Cystic Fibrosis Docosahexaenoic Acid Drug Drug Efficacy Female Fish Oil Hospitalization Human Eicosapentaenoic Acid Lung Disease Lung Function Omega 3 Fatty Acid Oral Drug Administration Priority Journal Supplementation |
| Issue Date: | 1997 |
| Date Accessioned: | 2023-04-12T02:09:38Z |
| Date Available: | 2023-04-12T02:09:38Z |
| Url: | https://doi.org/10.1111/j.1440-1754.1997.tb01615.x |
| Description Affiliation: | N.H. Thies, 238 Lava Street, Warrnambool Base Hospital, Victoria, Australia. |
| Format Startpage: | 349-351 |
| Source Volume: | 33 |
| Issue Number: | 4 |
| Date: | 1997 |
| Abstract: | Five children with cystic fibrosis (CF) and chronic suppurative lung disease had eicosapentaenoic acid (EPA) supplementation for 12 months. Outcome was measured by the change in frequency of admissions/bed days while taking EPA compared to the previous 2 years: Although no significant changes occurred, there is an indication that this treatment may benefit children who don't have end-stage disease. Further studies are indicated in the use of this neglected mode of treatment. |
| URI: | https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3698 |
| Journal Title: | Journal of Paediatrics and Child Health |
| Type: | Journal Article |
| Appears in Collections: | SWH Staff Publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.